New data from proof-of-concept study provides roadmap for treatment of ovarian cancer CAMBRIDGE, Mass., Jan. 14, 2025 — Eterna Therapeutics (NASDAQ: ERNA), a leader in cell therapies for the treatment of advanced solid tumors, today […]
Pathologic Complete Response reported for 2 patients with cutaneous Squamous Cell Carcinoma Marlborough, Massachusetts– January 13, 2025) – Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its INTASYL® siRNA […]
Initial order placed with Company’s distributor at contracted price and represents operational implementation through VA Federal Supply Schedule (FSS) Contract NEWTOWN, Pa., Dec. 23, 2024 — Helius Medical Technologies, Inc. (NASDAQ:HSDT) (“Helius” or the “Company”), […]
– Updated data for IMM-1-104 in combination with modified gemcitabine/nab-paclitaxel (mGnP) in first-line pancreatic cancer patients show favorable overall response rate (ORR = 43%) and disease control rate (DCR = 86%); planning for pivotal trial […]
MultiSensor AI Holdings, Inc. (“MultiSensor AI,” “MSAI” or “Company”) (NASDAQ:MSAI), a pioneer in the emerging industrial AI-driven condition-based maintenance and process solution industry, today announced additional changes to its management team to further align with […]
PLEASANTON, Calif., January 06, 2025—-AEye, Inc. (Nasdaq: LIDR), a global leader in adaptive, high-performance lidar solutions, today announced an update on 4Sight’s™ record-breaking, behind-the-windshield performance. AEye CEO Matt Fisch said, “Our talented team continues to […]
ENGLEWOOD, Colo., Dec. 10, 2024 — XTI Aerospace, Inc. (“XTI”) (Nasdaq: XTIA), a pioneer in advanced aircraft design, today announced that XTI conducted a General Familiarization (“Gen Fam”) presentation for the TriFan 600 with the Federal […]
Company Targeting Additional Auto OEMs After Recent BYD Partnership Win Fort Lauderdale, FL, Dec. 24, 2024 — Algorhythm Holdings, Inc. (“Algorhythm”) (NASDAQ: RIME) – an AI technology and consumer electronics holding company, announced today that is […]
Glucotrack to Present at TechBio Showcase™ 2025 RUTHERFORD, N.J., Jan. 07, 2025 — Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical technology company focused on the design, development, and commercialization of novel technologies […]
Arbe to Showcase How Rich, Ultra-High-Definition Perception Radar Transforms Vehicle Safety and Autonomy at CES 2025 TEL AVIV, Israel, Jan. 6, 2025 / — Arbe Robotics Ltd. (NASDAQ: ARBE) (TASE: ARBE), a global leader in Perception […]
Disney to combine its Hulu + Live TV business with Fubo and become majority owner of the resulting company The combined business will operate under the Fubo publicly traded company name (NYSE: FUBO) led by […]
TEL AVIV, Israel, Jan. 06, 2025 — SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, announced today […]
The approval was obtained from the Melz Municipal Committee in connection with the submission of Solterra’s statutory plan for the PV Project Neve Yarak, Israel, Jan. 02, 2025 — N2OFF, Inc.\ (NASDAQ: NITO) (FSE:80W) (“N2OFF” and the “Company”), a clean tech […]
REDMOND, Ore., Jan. 02, 2025 — Expion360 Inc. (Nasdaq: XPON) (“Expion360” or the “Company”), an industry leader in lithium-ion battery power storage solutions, announced today that it has begun distribution of its e360 Home Energy Storage […]
NEWPORT BEACH, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) — PMGC Holdings Inc (NASDAQ: ELAB), a diversified holding company, and Carmell Corporation (Nasdaq: CTCX), a bio-aesthetics company focused on skin and hair health (“Carmell”, the “Company”, […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
